Cost-utility analysis and cross-country comparison of pharmacogenomics-guided treatment in colorectal cancer patients participating in the U-PGx PREPARE study

Cost-utility analysis and cross-country comparison of pharmacogenomics-guided treatment in colorectal cancer patients participating in the U-PGx PREPARE study

Objectives: A cost-utility analysis was conducted to evaluate pharmacogenomic (PGx)-guided treatment compared to the standard-of-care intervention among patients diagnosed with colorectal cancer (CRC) in Italy. Methods: Data derived from a prospective, open-label, block randomized clinical trial, as...

Full description

Bibliographic Details
Main Authors: Vasileios Fragoulakis, Rossana Roncato, Alessia Bignucolo, George P. Patrinos, Giuseppe Toffoli, Erika Cecchin, Christina Mitropoulou
Format: Article
Language:English
Published: Elsevier 2023-11-01
Series:Pharmacological Research
Subjects:
Cost-utility analysis
Economic evaluation
Colorectal cancer
DPYD, UGT1A1
Adverse Drug Reactions
Fluoropyrimidines
Online Access:http://www.sciencedirect.com/science/article/pii/S1043661823003055

Internet

http://www.sciencedirect.com/science/article/pii/S1043661823003055

Similar Items